Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 4, Pages 1682-1697Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm201512x
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [UO1 CA89566]
- Purdue Research Foundation
- National Cancer Institute
Ask authors/readers for more resources
A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top 1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model sandwich complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the pi-pi stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug's Top1 inhibitory activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available